Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EV/Core EBITDA

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 32.66153.69244.10

What is the latest EV/Core EBITDA ratio of GENPHARMASEC ?

The latest EV/Core EBITDA ratio of GENPHARMASEC is 32.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202532.66
Mar2024153.69
Mar2023244.10

How is EV/Core EBITDA of GENPHARMASEC Trending?

Years EV/Core EBITDA % Change
Mar2025 32.66
-78.75
Mar2024 153.69
-37.04
Mar2023 244.1 -

Other Financial Ratios of GENPHARMASEC


Compare EV/Core EBITDA ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹43.2 Cr -15.2% -41.4% -58.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,874.7 Cr -1.7% -16.3% -22.8% Stock Analytics
KIRI INDUSTRIES ₹2,021.6 Cr -6.1% -25.8% -44% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,365.5 Cr 2.2% -10.1% -40.9% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹975.3 Cr 9.5% -4.1% 5.3% Stock Analytics
BODAL CHEMICALS ₹645.3 Cr -10% 9.1% -13.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-15.2%

-41.4%

-58.4%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses